Brian McKelligon, President/CEO at Akoya Biosciences, Inc. (AKYA), sold 5,000 shares at $12.08 ($60K) on 2022-12-06, disclosed to the SEC on 2022-12-08.
Open-market sale of $60k AKYA by President/CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKYA | SELL | 2024-03-22 | $37K | — | Filing → |
| AKYA | SELL | 2024-03-22 | $37K | — | Filing → |
| AKYA | SELL | 2023-12-20 | $34K | — | Filing → |